Benzaldehyde, 3-methyl-,[6-(4-morpholinyl)-2-[2-(2-pyridinyl)ethoxy]-4-pyrimidinyl]hydrazone,dimethanesulfonate
| Title | Journal |
|---|---|
| Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma. | Blood 20170330 |
| PIKfyve, a class III PI kinase, is the target of the small molecular IL-12/IL-23 inhibitor apilimod and a player in Toll-like receptor signaling. | Chemistry & biology 20130725 |
| Brief report: a phase IIa, randomized, double-blind, placebo-controlled trial of apilimod mesylate, an interleukin-12/interleukin-23 inhibitor, in patients with rheumatoid arthritis. | Arthritis and rheumatism 20120601 |
| Apilimod inhibits the production of IL-12 and IL-23 and reduces dendritic cell infiltration in psoriasis. | PloS one 20120101 |
| Therapeutic effect of the potent IL-12/IL-23 inhibitor STA-5326 on experimental autoimmune uveoretinitis. | Arthritis research & therapy 20080101 |
| Selective abrogation of Th1 response by STA-5326, a potent IL-12/IL-23 inhibitor. | Blood 20070201 |
| Drug evaluation: apilimod, an oral IL-12/IL-23 inhibitor for the treatment of autoimmune diseases and common variable immunodeficiency. | IDrugs : the investigational drugs journal 20070101 |